SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-007857
Filing Date
2015-05-14
Accepted
2015-05-14 19:34:16
Documents
2
Period of Report
2015-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1749
2 POWER OF ATTORNEY ex24bruder.txt EX-24 4287
  Complete submission text file 0001179110-15-007857.txt   7471
Mailing Address C/O BELLEROPHON THERAPEUTICS 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address
Bruder Scott P (Reporting) CIK: 0001411721 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36845 | Film No.: 15864923

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations